Japan's unapproved drug initiative makes headway
This article was originally published in Scrip
Executive Summary
A special committee on unapproved drugs set up under Japan's ministry of health, labour and welfare had considered 46 products by the end of June this year, 16 of which had progressed to regulatory approval, a new progress report reveals.